It seems that despite the obvious evidence and testimonials from people who have suffered a variety of conditions and diseases, the US Government is still turning a blind eye in favor of BigPharma when it comes to cannabis treatment. Which is even more infuriating is the fact that this refers to CBD too!
CBD is a cannabinoid extracted from the Marijuana plant which doesn’t contain the psychoactive properties of THC. It can be used for aid in the treatment of a variety of conditions from epilepsy to cancer.
This doesn’t only affect the people who are in dire need of the medicine directly, but also indirectly. Scientists who want to do research on CBD are now having a hard time complying to the DEA regulations too. This is mainly because the new labeling requires researchers to specify whether they intend to work only on extracts.
This action stops researchers from developing functional and legal medicine for a wide use and it is surely a step backwards in the efforts to create new cannabis based medications and treatments.
Effective from January 13 2017, the DEA stated that “extracts of marihuana will continue to be treated as Schedule I controlled substances,” with changes in the labeling which state the following:
“For practical purposes, all extracts that contain CBD will also contain at least small amounts of other cannabinoids. However, if it were possible to produce from the cannabis plant an extract that contained only CBD and no other cannabinoids, such an extract would fall within the new drug code 7350.”
At the same time, the UK are taking a step forward
The UK have rightly reclassified CBD as a medicine, with a spokesperson from the MHRA (Medicine and Healthcare products Regulatory Agency) stating: “We have come to the opinion that products containing cannabidiol (CBD) used for medical purposes are a medicine.“
This decision has been based on credible cases and claims that CBD can successfully treat some serious diseases.
This new classification means that products that contain CBD can be widely distributed and used throughout the UK.
“MHRA will now work with individual companies and trade bodies in relation to making sure products containing CBD, used for a medical purpose, which can be classified as medicines, satisfy the legal requirements of the Human Medicines Regulations 2012.”
Gerald Heddell, director of inspection and enforcement at MHRA, told the Sky News that “The change really came about with us offering an opinion that CBD is in fact a medicine, and that opinion was based on the fact that we noted that people were making some quite stark claims about serious diseases that could be treated with CBD.”
Would you stand for the injustice brought upon many, in favor of few?